Issue Of Equity And Total Voting Rights
Issue of Equity and Total Voting Rights
LEI Code 213800TKJUY376H3KN16
Albion Technology & General VCT PLC (the "Company") announces that, further to the Dividend Reinvestment Scheme (details of which were set out in the Circular issued to shareholders on 18 April 2008) the Company allotted 1,376,604 Ordinary shares of 1 penny each (the "new Ordinary shares") in the capital of the Company on 31 October 2025. The new Ordinary shares were issued at a price of 68.93p per Ordinary share, comprising the most recent net asset value of 70.70p per share less the dividend of 1.77p per Ordinary share.
Application has been made for the admission of the 1,376,604 new Ordinary shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities and it is expected that dealings will commence on or around 3 November 2025. The new Ordinary shares will rank pari passu in all respects with the existing Ordinary shares in issue.
Following the issue of the new Ordinary shares, the capital of the Company as at 31 October 2025 consists of 411,081,989 Ordinary shares of which 32,370,947 Ordinary shares are held in treasury.
Therefore, the total number of voting rights in the Company is 378,711,042. These figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
31 October 2025
For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP
Tel: 020 7601 1850

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment